TALLIN PATTERSON: Open Payments
NPI 1831608165 · BURBANK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,739 in 99 payments from 11 companies in 2025. Trend: 2023 $1,392 · 2024 $1,862 · 2025 $2,739
Food & beverage: $2,739
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $525 |
| Xeris Pharmaceuticals, Inc. | 15 | $352 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $347 |
| Radius Health, Inc. | 12 | $322 |
| ABBVIE INC. | 11 | $274 |
| Azurity Pharmaceuticals, Inc. | 12 | $249 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $183 |
| Esperion Therapeutics, Inc. | 6 | $149 |
| Lilly USA, LLC | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 1 | $123 |
Products named: GVOKE HYPOPEN, RELISTOR, TEPEZZA, QULIPTA, Kerendia, HORIZANT, NEXLETOL, MOUNJARO.
Industry payments across CA — which companies pay providers there.
